Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Mar 4, 2025, after the close
10-K filed Mar 4, 2025, 63 days after period end · 0001558370-25-002169
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $57.60M | $35.79M | $51.28M | $20.41M |
| Net Income | $14.34M |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| $737.00K |
| $1.40M |
| -$22.64M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
